Furthermore, inhibition of VEGFR2 through either ZM323881 or DC101 treatment inhibited MDA MB231 induced neurite growth highlighting that VEGF-A/VEGFR2 signalling is an important regulator of breast cancer induced sensory neuritogenesis. This evidence concerns the gene KDR and breast carcinoma.